Lenvatinib for Liver Cancer Approved in Europe Lenvatinib for Liver Cancer Approved in Europe

The European Commission granted marketing authorization to lenvatinib as first-line treatment in advanced or unresectable hepatocellular carcinoma.International Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news